Craig R. Nichols

Suggest Changes
Learn More
BACKGROUND With treatment leading to nearly uniform cure in clinical stage I nonseminomatous testicular cancer (CSI-NSGCT), diminishing treatment-related morbidity has become the primary concern.(More)